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Abstract
The purpose of this study is to develop a reliable in vitro human model to test new immunotherapeutic approaches for
squamous cell carcinoma that develop on mucosal surfaces. The organotypic (raft) culture permits cells to proliferate and
differentiate at an air–liquid interface on a dermal equivalent support. Normal keratinocytes stratify and fully differentiate in a
manner similar to the normal squamous epithelial tissues, while human papillomavirus-immortalized and established squamous
carcinoma cell lines exhibit dysplastic morphologies similar to (pre)neoplastic lesions seen in vivo. We have demonstrated the
ability of these organotypic cultures to be manipulated by altering the epithelial stratification with cytokines (interferon-g and
tumor necrosis factor-a) and by integrating activated lymphocytes or dendritic cells into the in vitro formed epithelial sheet. This
model may provide a useful tool to investigate the factors contributing to the presence and function of immunocompetent cells
within a neoplastic epithelium that develops on a mucosal surface. © 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Cancers associated with potentially oncogenic viruses
represent good models for research aimed at developing
anti-tumoral vaccines since viral proteins could serve as
tumor antigens. One of the most actively investigated
examples of a tumor-associated virus is the human
papillomavirus (HPV). Infection by specific types of
HPV (most notably HPV 16 and HPV 18) is strongly
implicated as a causative agent in the etiology of cervi-
cal cancer and its precursors, which are designated as
cervical intraepithelial neoplasia or squamous intraep-
ithelial lesions (SILs) (for a review, see Ref. [1]). The
generation of an effective protective immune response
in tumors is, however, still poorly understood and may
be influenced by factors produced by neoplastic and
infiltrating immune cells. Because different patterns of
synergism or antagonism may be observed between
these factors, preliminary studies of immunotherapeutic
manipulations should be performed in models approxi-
mating the in vivo environment of the tissue of origin.
The purpose of this study is to develop a reliable in
vitro human model to test new immunotherapeutic
approaches for squamous cell carcinoma that develop
on mucosal surfaces and particularly in the uterine
cervix. The organotypic (raft) culture permits cells to
proliferate and differentiate at an air–liquid interface
on a dermal-equivalent support. Normal keratinocytes
stratify and fully differentiate in a manner similar to the
normal squamous epithelial tissues, while HPV-immor-
talized and established squamous carcinoma cell lines
exhibit dysplastic morphologies similar to
(pre)neoplastic lesions seen in vivo. The ability of these
organotypic cultures to be manipulated may provide a
useful tool to investigate the immune factors contribut-
ing to eliminate a neoplastic epithelium developed on a
mucosal surface.
Interferon-gamma (IFN-g) and tumor necrosis fac-
tor-alpha (TNF-a) are regulatory cytokines with
pleiotropic biological activities including antiprolifera-
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tive, antiviral and immunomodulatory activities [2–5].
They are capable of modulating the expression of cell
surface molecules, e.g. HLA class II antigens and inter-
cellular adhesion molecules, with a pivotal role in the
interactions of neoplastic or infected cells with the
host’s immune system [4]. The loss of responsiveness to
these cytokines by neoplastic keratinocytes might repre-
sent a potential mechanism by which the transformed
cells escape destruction by the host’s immune system.
The most effective mechanism for tumor cell destruc-
tion is likely to be cytotoxic T lymphocyte (CTL)
responses. T lymphocytes are observed in HPV-associ-
ated cervical lesions but there is some evidence that
they are poorly activated [6]. Specific CTL against HPV
have been detected in T lymphocytes infiltrating cervi-
cal lesions, but only in a minority of patients [7].
Professional antigen-presenting cells, such as Langer-
hans cells, also exhibit quantitative and qualitative al-
terations in SILs [8–11].
In this study, we demonstrated that the organotypic
culture of HPV-transformed keratinocytes is a conve-
nient and bona fide in vitro model to examine the effect
of cytokines on the growth of HPV-transformed kerati-
nocytes and the ability of immunocompetent cells to
infiltrate a (pre)neoplastic epithelium.
2. Materials and methods
2.1. Culture of normal cer6ical keratinocytes
Human exocervical epithelial cells were obtained
from hysterectomy specimens of healthy women. The
operations were performed for disease unrelated to the
cervix. Cell cultures were established and maintained
following a previously reported method [12]. Subconflu-
ent cultures were dispersed with 0.0025% trypsin and
0.02% ethylenediamine tetraacetic acid. These primary
cultures of keratinocytes were used for the organotypic
cultures.
2.2. HPV-transformed keratinocyte cell lines
SiHa, CasKi, and C4-II are tumorigenic cervical
carcinoma-derived keratinocyte cell lines [13–15]. The
SiHa cell line contains one copy of integrated HPV 16
DNA. The CasKi cell line contains approximately 600
copies of integrated HPV 16 DNA, whereas the C4-II
cell line contains HPV 18 DNA sequences. The CK2
cell line was established by transfection of human cervi-
cal keratinocytes with HPV-33 DNA and is not tumori-
genic in nude mice [12]. Two cell lines (supplied by Dr
J.K. McDougall) established by transfection of human
foreskin keratinocytes with HPV 16 DNA (EIL8; non-
tumorigenic) or HPV 18 DNA (18-11S3; tumorigenic
after 60 passages in tissue culture) were also tested for
response to IFN-g and:or TNF-a [16]. All these HPV-
transformed keratinocyte cell lines were grown and
maintained in a mixture of HAM F12 and DMEM
supplemented with the same additives as those used for
normal keratinocyte cultures.
2.3. Cytokines
Human rIFN-g (2107 U:mg) and rTNF-a (4.9
107 U:mg) were kindly provided by Boehringer Ingel-
heim International. IFN-g and TNF-a production in
peripheral blood mononuclear cell (PBMC) cultures
was determined using an ELISA assay (Medgenix Diag-
nostics S.A. Fleurus, Belgium).
2.4. PBMC cultures
PBMC were isolated from the buffy coat of healthy
donors by centrifugation on Lymphoprep (Nycomed,
Oslo, Norway) following standard protocols. For stim-
ulation, cells were cultivated (1.25106 cells:ml) in the
presence of 10 ng:ml anti-CD3 mAb kindly provided by
Dr Kurrle Behringwerke (Marburg, Germany) and:or
50 U:ml human rIL-2 kindly provided by Glaxo Insti-
tute for Molecular Biology (AG, Gene`ve, Switzerland)
during 4 days.
2.5. Dendritic cell cultures
Dendritic cells (DC) were generated by culturing
adherent fractions of human PBMC as previously de-
scribed [17]. The phenotype of the cells was verified by
flow cytometric cell surface marker analysis using
anti-CD14, anti-CD1a, anti-CD4 and anti-CD3 anti-
bodies.
2.6. Organotypic cultures
Organotypic cultures of normal cervical kerati-
nocytes and HPV-transformed keratinocytes were pre-
pared by using procedures slightly modified from those
described previously [16]. For the preparation of dermal
equivalents, a collagen matrix solution was made with
32 mg collagen (cellagen solution AC-5, type I; ICN
Biomedical, Asse-Relegen, Belgium) mixed on ice with
1.6 ml of 0.1% acetic acid, 1 ml chilled tenfold concen-
trated Hank’s buffer supplemented with phenol red and
1 N NaOH to give pH 7.2. One milliliter of fetal calf
serum containing 4105 normal human fibroblasts was
then added. One milliliter of the collagen-fibroblasts
solution was poured into 24-well plates (Nunclon D
Multidishes, NUNC, Denmark) and allowed to solidify
at 37°C for 1H. The final concentrations of collagen
and fibroblasts were 3.2 mg:ml and 4104 cells:ml,
respectively. After gel equilibration with 1 ml growth
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medium overnight at 37°C, 25104–1106 kerati-
nocytes (normal or HPV-transformed) resuspended in
100 ml growth medium were seeded on top of the gels
and maintained submerged for 24–96 h. The collagen
rafts were raised in a 25 mm tissue culture insert (8 mm
pore size; NUNC, Denmark) and placed onto stainless-
steel grids, at the interface between air and liquid
culture medium. Epithelial cells were then allowed to
stratify for 10–15 days. Hematoxylin eosin staining and
standard immunohistological techniques with antibod-
ies against markers of cell proliferation (MIB-1; Im-
munotech S.A.), differentiation (involucrin;
Novocastra), cell adhesion (E-cadherin, HECD-1;
Boehringer Ingelheim International) were first used to
assess the degree of similarity between the in vitro
formed epithelial sheet and the in vivo observed epithe-
lium. We next determined whether these organotypic
cultures can be manipulated. For the cytokine experi-
ments, medium added or not with either IFN-g (1000
U:ml), TNF-a (1000 U:ml) or IFN-g (1000 U:ml) in
combination with TNF-a (1000 U:ml) was changed
every 2–3 days. Organotypic cultures then were fixed in
10% neutral buffered formaldehyde, paraffin-
embedded, sectioned and stained with hematoxylin and
eosin or immunolabeled with the MIB-1 monoclonal
antibody specific for Ki-67 antigen. For other experi-
ments, the PBMC and DC were seeded on top of the in
vitro formed epithelium after stratification of kerati-
nocyte. The PBMC and DC concentrations were 106
cells:50 ml and 2105 cells:50 ml growth medium,
respectively. For the DC experiments, organotypic cul-
ture medium was supplemented or not with 800 U:ml
granulocyte macrophage-colony stimulating factor
(GM-CSF). After 24–72 h at 37°C, the collagen rafts
were harvested. The cultures were then embedded in
O.C.T. compound (Tissue Tek, Sakura, Netherlands) at
70°C and sectioned with a cryostat microtome for
the immunohistochemical analysis. The density of T
lymphocytes and DC migrating into the epithelial layer
was assessed by a standard avidin–biotin–peroxidase
technique with monoclonal antibodies specific for CD3,
CD45 (Becton Dickinson, Erembodegem, Belgium)
and CD1a (clone NA1:34 from Dako, Glostrup, Den-
mark).
2.7. MTT assay
HPV cell lines were seeded at a concentration of
2.5103 cells:microwell in 200 ml culture medium con-
taining 100 or 25 ml PBMC culture supernatant. The
cells were incubated 4 days at 37°C and 5% CO2. In
each well, 10 ml cell proliferation reagent WTS-1 (tetra-
zolium salt; Boehringer Mannheim) were added and
incubated for 4 h at 37°C and 5% CO2. The absorbance
of the sample was measured at 440 nm with a microtiter
plate reader.
3. Results
3.1. Assessment of the degree of similarity between the
in 6itro formed epithelial sheet and the in 6i6o obser6ed
epithelium
After 10–15 days, normal keratinocytes produced
differentiated epithelial layers of about ten cells in
thickness morphologically similar to a normal
squamous exocervical epithelium (Fig. 1A,B), whereas
HPV-transformed keratinocytes produced an epithelial
sheet of up to 10–15 cells in thickness [18] (Fig. 1C).
These cells appeared disorganized and highly atypical
throughout its full thickness, reminiscent of high-grade
cervical lesions (Fig. 1D). Ki-67 antigen was expressed
throughout the full thickness of the epithelium, as
already observed in biopsy specimens of high-grade SIL
[9] (Fig. 1E,F). In contrast, the normal cervix and
normal keratinocyte raft cultures showed important
staining for the differentiation marker, involucrin,
whereas this staining was absent or limited to the
superficial cell layers for both HPV keratinocyte raft
cultures and (pre)neoplastic lesions of the cervix (data
not shown). There was also a decreased cell membrane
staining of the cell adhesion molecule, E-cadherin, in
SILs of the cervix and in organotypic cultures of HPV-
transformed keratinocytes compared with the normal
exocervical epithelium and organotypic cultures of nor-
mal keratinocytes (data not shown).
3.2. Effect of IFN-g and TNF-a on normal and
HPV-transformed keratinocytes in organotypic cultures
The growth of normal keratinocytes in organotypic
cultures was inhibited by IFN-g, TNF-a and IFN-g
associated to TNF-a. This antiproliferative effect of
cytokines was reflected by the impairment of normal
epithelial stratification that was reduced to a few cells
in thickness. The stratification and immunostaining for
Ki-67 antigen of HPV-transformed keratinocytes were
dramatically decreased in the presence of IFN-g and
IFN-g associated to TNF-a (Fig. 2A,B). A more pro-
nounced effect was observed with the combination of
IFN-g and TNF-a. TNF-a alone, at a concentration of
1000 U:ml, did not significantly alter the stratification-
proliferation of the HPV-transformed cell lines [18].
3.3. Infiltration of PBMC into organotypic cultures of
HPV-transformed keratinocytes
After 24 h of co-culture with the keratinocyte rafts,
mononuclear cells (detected by anti-CD45 mAb) were
observed in the epithelial sheet. The majority of these
cells were T lymphocytes as shown by the anti-CD3
labeling (data not shown). The density of IL-2anti-
CD3 mAb-stimulated PBMC infiltrating the epithelial
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Fig. 1. Normal and HPV-transformed keratinocyte organotypic cultures as models of normal squamous epithelium and high-grade cervical lesions,
respectively (A–D: hematoxylin–eosin). (A) Section of an organotypic culture of normal cervical keratinocytes. (B) Biopsy specimen of normal
exocervical squamous epithelium. (C) Section of an organotypic culture of SiHa cells. (D) Biopsy specimen of high-grade cervical SIL. (E–F) Ki67
antigen-immunostained sections of an organotypic culture of HPV-transformed keratinocytes (E) and a biopsy specimen of high-grade cervical
lesion (F).
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Fig. 2. Representative examples of organotypic cultures of HPV-transformed keratinocytes supplemented by cytokines and:or infiltrated by
immunocompetent cells. Hematoxylin–eosin stained sections of organotypic cultures of SiHa cells in the absence (A) or in the presence (B) of
IFNg associated with TNFa. CD45-immunolabeled sections of organotypic cultures of SiHa cells infiltrated by resting PBMC (C) or by PBMC
stimulated with IL-2anti-CD3 (D). CD1a-immunolabeled sections of organotypic cultures of SiHa cells infiltrated by dendritic cells in the
absence (E) or in the presence (F) of GM-CSF.
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Fig. 3. IFN-g and TNF-a production in cultures of unstimulated (medium) or stimulated PBMC (IL-2 or IL-2anti-CD3 mAb).
sheet was higher than that of unstimulated or IL-2-
stimulated T lymphocytes (Fig. 2C,D). These PBMC
had a cytotoxic effect since apoptotic keratinocytes
were detected in organotypic cultures [19]. Interestingly,
IL-2anti-CD3 mAb-activated PBMC produced high
amounts of IFN-g and TNF-a (Fig. 3), and the super-
natant of these cultures inhibited the proliferation of
HPV cell lines (Fig. 4), suggesting that IFN-g and
TNF-a could participate in the cytotoxic effect ob-
served in organotypic cultures.
3.4. Infiltration of DC into organotypic cultures of
HPV-transformed keratinocytes
Fig. 2E–F illustrates representative experiments
showing the density of CD1a-labeled DC in HPV-trans-
formed organotypic cultures incubated with or without
exogenous GM-CSF. In organotypic cultures of normal
keratinocytes, DC migrated in a similar manner in the
presence or in the absence of GM-CSF [20]. In con-
trast, DC layered onto organotypic cultures of SiHa
poorly infiltrated the epithelial layer in the absence of
GM-CSF (Fig. 2E), whereas addition of GM-CSF
caused an important increase in the density of DC
observed in the epithelial layer (Fig. 2F).
4. Discussion
Because the validation of new treatments based on
the stimulation of the immune system of the host may
benefit from studies performed with in vitro models
mimicking many in vivo features, we developed an
organotypic culture system that permits epithelial cells
to proliferate and differentiate at an air–liquid interface
on a dermal equivalent support. Normal keratinocytes
stratify and fully differentiate in a manner similar to the
normal squamous epithelial tissues, while HPV-immor-
talized and established squamous carcinoma cell lines
exhibit dysplastic morphologies similar to
(pre)neoplastic squamous lesions seen in vivo.
Morphological and immunohistological techniques
with antibodies against markers of cell proliferation,
differentiation, and cell adhesion were first used to
assess the degree of similarity between the in vitro
formed epithelial sheet and the in vivo observed epithe-
lium. Our results demonstrated that the organotypic
(raft) culture is not simply constituted by a random
accumulation of cells, but also reproduces faithfully
normal or (pre)neoplastic epithelial tissues, as observed
in vivo. We next demonstrated the ability of these
Fig. 4. Inhibition of HPV cell line proliferation by culture superna-
tants of unstimulated (medium) or stimulated PBMC (IL-2 or IL-2
anti-CD3 mAb). Two dilutions of supernatants were used (1:2 and
1:8). Means9S,D, of two or three independent experiments are
shown.
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organotypic cultures to be manipulated. We showed
that HPV-transformed keratinocytes do not lose their
sensitivity to the antiproliferative effect of IFN-g alone
or associated with TNF-a, compared with normal ker-
atinocytes. These results associated to the demonstra-
tion of a localized immunodepletion in HPV-related
lesions [10,21] suggest that these recombinant cytokines
might be useful in the treatment of cervical HPV-associ-
ated cervical lesions. We also succeeded to integrate in
these in vitro formed epithelial sheets some types of
immunocompetent cells. Since intra-epithelial T
lymphocytes have been shown to be depleted in cervical
SIL [22,23] and to increase in spontaneously regressing
HPV-associated genital warts [24], the cell-mediated
immune response probably plays a crucial role in host
defence against HPV infection and associated-
(pre)cancerous lesions, perhaps via the production of
IFN-g and TNF-a. The establishment of an in vitro
model allowing for the investigation of the factors
contributing to the presence and function of immuno-
competent cells within a dysplastic epithelium is there-
fore relevant. Since tissue cells cultivated on plastic are
in an environment that does not prevail in vivo, organ-
otypic cultures present a very promising in vitro model
for testing the ability of immune cells to infiltrate a
pre-neoplastic epithelium. To evaluate the feasibility of
this model, as a first step, we have studied the infiltra-
tion of resting and activated allogeneic PBMC into an
organotypic culture of HPV-transformed keratinocytes.
The PBMC were activated by IL-2 and IL-2anti-
CD3 to allow the generation of LAK cells, as already
used in immunotherapeutical protocols [25]. The activa-
tion in the presence of anti-CD3 mAb induced an
increase in the proportion of T lymphocytes as we
previously showed [26]. Although unstimulated and
stimulated lymphocytes were able to penetrate SiHa
organotypic cultures, the stimulated lymphocytes
infiltrated the cultures more rapidly and in higher num-
bers, especially after activation with IL-2anti-CD3
mAb. Most of the infiltrating lymphocytes were T cells.
These results highlight the potential interest of organ-
otypic cultures of HPV-transformed keratinocytes as a
model for studying the ability of lymphocytes to mi-
grate into a (pre)neoplastic epithelium. Other models
are, however, necessary to analyse the ability of
lymphoid cells to cross the basement membrane, such
as those using a three-dimensional collagen matrix
[27,28].
As most pre-neoplastic lesions of the cervix are asso-
ciated with a significant depletion of intra-epithelial
Langerhans cells, when compared with normal cervix
epithelium [8,9,11], we also investigated the migration
of in vitro generated DC in the presence of kerati-
nocytes derived from normal cervix and HPV-trans-
formed cell lines in organotypic cultures. We and other
workers have observed that HPV keratinocytes cell
lines produce less GM-CSF than normal keratinocytes
[29]. Since GM-CSF is an essential factor not only for
the maturation and differentiation of DC but also for
their motility [30], we tested the capacity of this cy-
tokine to influence the ability of DC to colonize an in
vitro formed (pre)neoplastic epithelium. Under basal
conditions, the level of DC infiltration in cultures of
normal keratinocytes was higher than that of HPV
cell lines cultures. Except for one cell line, a positive
correlation was observed for the numbers of CD1a
cells present in the epithelial layer and the amount of
GM-CSF produced by the HPV cell lines (data not
shown). When the medium of organotypic cultures of
HPV cell lines was supplemented with GM-CSF, the
infiltration of DC improved and reached an infiltration
level equivalent to that obtained with normal kerati-
nocytes. These findings suggest that a treatment based
on GM-CSF may restore some immunologic functions
that have been shown to be altered during the progres-
sion of cervical SILs.
In conclusion, this study highlights the potential in-
terest of the organotypic culture of HPV-transformed
keratinocytes for the design of new immunotherapeutic
strategies. The ability of this model to be manipulated
(for example, by integrating cytokines and:or immuno-
competent cells) may also provide a useful tool to
investigate the factors contributing to the presence and
function of immunocompetent cells within a neoplastic
epithelium.
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